All of the other families would therefore require further optimization before being ready for an in vivo proof-of-concept assay.
Though this is just a proof-of-concept assay example, malaria is an interesting target for an inexpensive highly sensitive point-of-care diagnostic test, because while current malaria rapid diagnostics have improved dramatically, these tests are insufficient for accurate diagnosis in settings where malaria control efforts have dramatically reduced the malaria rates in many endemic areas.
CLS performed all of the directed Y2H assays and assisted SC in library proof-of-concept assays.
By using this principle concept, an assay was constructed for the detection of AFB1.
The ideas include the difference between explanatory and pragmatic orientation in clinical trial design, approaches to studying groups of patients with heterogeneous disease mechanisms, the importance of placebo responses, and the concept of "assay sensitivity" in clinical trials.
It also describes several ideas useful in designing trials, including the difference between explanatory and pragmatic orientation in clinical trial design, approaches to study groups of patients with heterogeneous disease mechanisms, the importance of placebo responses, and the concept of "assay sensitivity" in clinical trials.
As proof of concept, several assays were combined and loaded on a single gel lane/capillary to substantially improve throughput.
As a proof-of-concept genetic assay, the novel signaling strategy, as well as desirable analytical capability, would significantly benefit the development of versatile amplification gene profiling platforms, revealing great promise in biological studies and medical diagnostics.
As a proof of concept, activity assays with one of the candidates, a putative chitinase, showed that functional protein was obtained using the low-temperature optimized vector suite.
To prove this concept in an assay system simulating the physiological conditions, we performed a hPBMC-based neutralization assay using primary HIV-1 isolates [17], [18].
